Section of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America.
PLoS One. 2013;8(2):e56096. doi: 10.1371/journal.pone.0056096. Epub 2013 Feb 5.
The prevalence of hypertension increases after menopause with 75% of postmenopausal women developing hypertension in the United States, along with hypertensive end organ diseases. While human and animal model studies have indicated a protective role for estrogen against cardiovascular disease and glomerulosclerosis, clinical studies of hormone replacement therapy in postmenopausal women have shown polar results with some improvement in hypertension but worsening of hypertensive kidney disease, or no effect at all. These observations suggest that the pathogenesis of postmenopausal hypertension and its target organ complications is more complex than projected, and that loss of endogenous estrogens induces epigenetic changes that alter genetic susceptibility to end-organ complications per se resulting in pathogenetic mechanisms beyond correction by hormone replacement. We studied postmenopausal-induced changes in renal disease and performed a total genome scan for quantitative trait loci (QTLs) affecting kidney disease in postmenopausal 16m-old F2[Dahl S x R]-intercross female rats. We used glomerular injury score (GIS) as quantitative trait. We compared QTLs amongst premenopausal, ovariectomized and postmenopausal F2[Dahl S x R]-intercross rats using identical phenotype characterization. Postmenopausal F2[Dahl S x R]-intercross rats exhibited increased hypertensive glomerulosclerosis (P<0.01) and equivalent levels of kidney disease when compared to premenopausal and ovariectomized F2[Dahl S x R]-intercross rats respectively. We detected three significant to highly significant GIS-QTLs (GIS-pm1 on chromosome 4, LOD 3.54; GIS-pm2 on chromosome 3, LOD 2.72; GIS-pm3 on chromosome 5, LOD 2.37) and two suggestive GIS-QTLs (GIS-pm4 on chromosome 2, LOD 1.70; GIS-pm5 on chromosome 7, LOD 1.28), all of which were unique to this postmenopausal population. Detection of increased renal disease phenotype in postmenopausal and ovariectomized subjects suggests a protective role of ovarian hormones. Furthermore, the detection of distinct GIS-QTLs in postmenopausal intercross female rats suggests that distinct genetic mechanisms underlie hypertensive glomerulosclerosis in premenopausal and postmenopausal states.
高血压的患病率在绝经后会增加,在美国,75%的绝经后妇女患有高血压和高血压的终末器官疾病。虽然人类和动物模型研究表明雌激素对心血管疾病和肾小球硬化有保护作用,但对绝经后妇女进行激素替代疗法的临床研究结果却截然相反,一些研究表明高血压有所改善,但高血压肾病恶化,或根本没有效果。这些观察结果表明,绝经后高血压及其靶器官并发症的发病机制比预期的更为复杂,内源性雌激素的丧失会诱导表观遗传改变,从而改变对终末器官并发症的遗传易感性,导致发病机制超出激素替代的纠正范围。我们研究了绝经后引起的肾脏疾病变化,并对绝经后 16 个月大的 F2[Dahl S x R]-杂交雌性大鼠的肾脏疾病进行了全基因组扫描,以寻找影响疾病的数量性状基因座(QTLs)。我们使用肾小球损伤评分(GIS)作为定量性状。我们在绝经前、去卵巢和绝经后 F2[Dahl S x R]-杂交大鼠中比较了 GIS 的 QTLs,并使用相同的表型特征进行了比较。与绝经前和去卵巢的 F2[Dahl S x R]-杂交大鼠相比,绝经后 F2[Dahl S x R]-杂交大鼠表现出高血压性肾小球硬化症增加(P<0.01)和相当水平的肾脏疾病。我们检测到三个显著到高度显著的 GIS-QTLs(GIS-pm1 在染色体 4 上,LOD 3.54;GIS-pm2 在染色体 3 上,LOD 2.72;GIS-pm3 在染色体 5 上,LOD 2.37)和两个提示 GIS-QTLs(GIS-pm4 在染色体 2 上,LOD 1.70;GIS-pm5 在染色体 7 上,LOD 1.28),所有这些 QTLs都是绝经后人群特有的。在绝经后和去卵巢的受试者中检测到肾脏疾病表型增加表明卵巢激素具有保护作用。此外,在绝经后杂交雌性大鼠中检测到不同的 GIS-QTLs 表明,绝经前和绝经后状态下高血压性肾小球硬化的遗传机制不同。